Asarina Pharma AB (FRA:APS) Other Current Receivables : €0.04 Mil (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Asarina Pharma AB Other Current Receivables?

Asarina Pharma AB's Other Current Receivables for the quarter that ended in Jun. 2023 was €0.04 Mil.

Asarina Pharma AB's quarterly Other Current Receivables declined from Jun. 2022 (€0.04 Mil) to Dec. 2022 (€0.03 Mil) but then increased from Dec. 2022 (€0.03 Mil) to Jun. 2023 (€0.04 Mil).

Asarina Pharma AB's annual Other Current Receivables increased from Dec. 2020 (€0.02 Mil) to Dec. 2021 (€0.03 Mil) but then declined from Dec. 2021 (€0.03 Mil) to Dec. 2022 (€0.03 Mil).

Asarina Pharma AB Other Current Receivables Historical Data

The historical data trend for Asarina Pharma AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Other Current Receivables Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Current Receivables

Get a 7-Day Free Trial

0.03

0.09

0.02

0.03

Asarina Pharma AB Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Other Current Receivables	Get a 7-Day Free Trial															0.03	0.03	0.04	0.03	0.04

Asarina Pharma AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Asarina Pharma AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB (FRA:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (FRA:APS) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

ASAP:Sweden

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB (FRA:APS) Headlines

No Headlines